Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New report from Prous Science reviews treatment options for patients with muscular dystrophy

May 31, 2006

Shire disappointed at NICE's recommendation on patients with mild Alzheimer's

May 31, 2006

Phase IIa trial studies Phosphagenics' transdermal morphine

May 31, 2006

Recent patents cover therapeutic agents for neurological disorders

May 30, 2006

Recent patents describe new analgesic agents

May 30, 2006

Translational Research developing intranasal granisetron

May 30, 2006

AT-3022 fentanyl citrate transdermal patch begins U.S. phase I trials

May 30, 2006

BioLineRx licenses BL-3010 from Gevys for acute and chronic pain

May 30, 2006

Elite begins second clinical study for ELI-154

May 30, 2006

Significant ADHD symptom control with shorter Daytrana wear time

May 30, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...